NCT07735286 Automating Tobacco Cessation in Primary Care
| NCT ID | NCT07735286 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pennsylvania |
| Condition | Tobacco Use |
| Study Type | INTERVENTIONAL |
| Enrollment | 4,800 participants |
| Start Date | 2026-09-24 |
| Primary Completion | 2027-03-23 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 4,800 participants in total. It began in 2026-09-24 with a primary completion date of 2027-03-23.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study focuses on improving how primary care teams identify patients who smoke and offer access to nicotine replacement therapy, or NRT. NRT includes medications such as nicotine patches, gum, or lozenges that can reduce cravings and support people who are interested in cutting back or quitting smoking. Although NRT is an evidence-based treatment option, it is not always discussed or prescribed during routine primary care visits. To better understand how NRT can be offered in primary care, the project will test a workflow at Penn Family Care that identifies patients who currently smoke and provides information about available tobacco treatment options. Edward Cooper Internal Medicine will serve as a comparison site. Patients who smoke and/or are prescribed NRT will also receive a 30-day follow-up survey to learn whether they received, picked up, or used NRT; whether it was useful; and what barriers they experienced.
Eligibility Criteria
Inclusion Criteria: * Age 18 years or older * Patient at Penn Family Care or Edward Cooper Internal Medicine * Had an eligible scheduled or completed practice visit categorized as a new annual visit, return patient visit, return annual visit, or return patient sick visit * For the tobacco cessation intervention: Penn Family Care patient who had not previously completed the tobacco questionnaire * For the 30-day follow-up survey: Active smoker in the EHR as of the completed visit date or prescribed nicotine replacement therapy (NRT) between 3 days before and 30 days after the completed visit date * For the primary analysis: Active smoker in the EHR as of the completed visit date * For the primary analysis: Did not have an NRT prescription between 34 and 4 days before the completed visit date Exclusion Criteria: * None except as specified in inclusion criteria.
Contact & Investigator
Cheryl Bettigole, MD, MPH
PRINCIPAL INVESTIGATOR
Penn Medicine
Frequently Asked Questions
Who can join the NCT07735286 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tobacco Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07735286 currently recruiting?
Yes, NCT07735286 is actively recruiting participants. Contact the research team at nathalie.laurent@pennmedicine.upenn.edu for enrollment information.
Where is the NCT07735286 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT07735286 clinical trial?
NCT07735286 is sponsored by University of Pennsylvania. The principal investigator is Cheryl Bettigole, MD, MPH at Penn Medicine. The trial plans to enroll 4,800 participants.